Analyst Ratings for Kailera Therapeutics (KLRA)

KLRA Rating Summary

KLRA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KLRA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $42.75 (+97.8%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/12/2026 Evercore ISI Umer Raffat New Coverage Outperform
(N/A)
N/A
(N/A)
22.93
(21.61)
-5.76% Details
5/12/2026 Leerink David R New Coverage Outperform
(N/A)
36.00
(N/A)
22.93
(21.61)
-5.76% Details